Retinal Microvascular Dysfunction Occurs Early and Similarly in Mild Alzheimer's Disease and Primary-Open Angle Glaucoma Patients.

Stephanie Mroczkowska, Hala Shokr, Alexandra Benavente-P��rez, Anil Negi, Peter Bentham, Doina Gherghel
Author Information
  1. Stephanie Mroczkowska: Vascular Research Laboratory, Ophthalmic Research Group, College Health and Life Sciences, Aston University, Birmingham B4 7ET, UK.
  2. Hala Shokr: Vascular Research Laboratory, Ophthalmic Research Group, College Health and Life Sciences, Aston University, Birmingham B4 7ET, UK. ORCID
  3. Alexandra Benavente-P��rez: Vascular Research Laboratory, Ophthalmic Research Group, College Health and Life Sciences, Aston University, Birmingham B4 7ET, UK.
  4. Anil Negi: Medical Innovation Development and Research Unit, University Hospitals Birmingham NHS Foundation Trust, Birmingham B15 1NT, UK.
  5. Peter Bentham: Medical Innovation Development and Research Unit, University Hospitals Birmingham NHS Foundation Trust, Birmingham B15 1NT, UK.
  6. Doina Gherghel: Vascular Research Laboratory, Ophthalmic Research Group, College Health and Life Sciences, Aston University, Birmingham B4 7ET, UK. ORCID

Abstract

Purpose: To assess the similarities and differences in retinal microvascular function between mild Alzheimer���s disease (AD) patients, early-stage primary open angle glaucoma (POAG) patients and healthy controls. Methods: Retinal vessel reactivity to flickering light was assessed in 10 AD, 19 POAG and 20 healthy age matched control patients by means of dynamic retinal vessel analysis (DVA, IMEDOS, GmbH, Jena, Germany) according to an established protocol. All patients additionally underwent BP measurements and blood analysis for glucose and lipid metabolism markers. Results: AD and POAG patients demonstrated comparable alterations in retinal artery reactivity, in the form of an increased arterial reaction time (RT) to flicker light on the final flicker cycle (p = 0.009), which was not replicated by healthy controls (p > 0.05). Furthermore, the sequential changes in RT on progressing from flicker one to flicker three were found to differ between healthy controls and the two disease groups (p = 0.001). Conclusion: AD and POAG patients demonstrate comparable signs of vascular dysfunction in their retinal arteries at the early stages of their disease process. This provides support for the concept of a common underlying vascular aetiology in these two neurodegenerative diseases.

Keywords

References

  1. Int Rev Psychiatry. 2011 Aug;23(4):365-70 [PMID: 22026493]
  2. Neurochem Res. 2011 Jan;36(1):163-9 [PMID: 20936504]
  3. FASEB J. 2011 Jan;25(1):5-13 [PMID: 21205781]
  4. J Clin Neurosci. 2006 Jun;13(5):563-8 [PMID: 16540327]
  5. Acta Ophthalmol. 2018 Dec;96(8):e956-e962 [PMID: 30198216]
  6. Invest Ophthalmol Vis Sci. 2012 May 04;53(5):2485-7 [PMID: 22562847]
  7. Clin Chem. 1972 Jun;18(6):499-502 [PMID: 4337382]
  8. Arch Ophthalmol. 2007 Apr;125(4):494-8 [PMID: 17420369]
  9. Vis Neurosci. 2005 May-Jun;22(3):371-7 [PMID: 16079011]
  10. Invest Ophthalmol Vis Sci. 2019 Aug 1;60(10):3447-3455 [PMID: 31408108]
  11. Eur Neurol. 2002;47(3):165-8 [PMID: 11914555]
  12. JAMA Ophthalmol. 2013 Jan;131(1):36-43 [PMID: 22964974]
  13. Alzheimers Res Ther. 2020 Dec 4;12(1):161 [PMID: 33276820]
  14. Acta Ophthalmol. 2012 Feb;90(1):e9-12 [PMID: 21955552]
  15. PLoS One. 2018 Oct 4;13(10):e0204689 [PMID: 30286110]
  16. Glia. 2021 Apr;69(4):817-841 [PMID: 33058289]
  17. Invest Ophthalmol Vis Sci. 2007 May;48(5):2285-9 [PMID: 17460292]
  18. Br J Ophthalmol. 2004 Jan;88(1):54-6 [PMID: 14693773]
  19. Exp Eye Res. 2011 Aug;93(2):170-7 [PMID: 20849847]
  20. Alzheimers Res Ther. 2017 Mar 1;9(1):13 [PMID: 28253913]
  21. Arch Ophthalmol. 1993 Jun;111(6):831-6 [PMID: 8512486]
  22. Geroscience. 2022 Aug;44(4):1-14 [PMID: 35612774]
  23. Transl Stroke Res. 2018 Jun;9(3):284-293 [PMID: 29119370]
  24. Am J Cardiovasc Dis. 2013 Nov 01;3(4):197-226 [PMID: 24224133]
  25. Antioxidants (Basel). 2021 Nov 03;10(11): [PMID: 34829627]
  26. Int J Geriatr Psychiatry. 2006 Nov;21(11):1078-85 [PMID: 16977673]
  27. Acta Ophthalmol. 2021 Nov;99(7):e1236-e1242 [PMID: 33576186]
  28. Acta Ophthalmol. 2012 Nov;90(7):e553-9 [PMID: 22998650]
  29. J Neurol Sci. 2006 Jul 15;246(1-2):79-83 [PMID: 16564058]
  30. Cells. 2022 Sep 28;11(19): [PMID: 36230999]
  31. Geroscience. 2019 Jun;41(3):341-349 [PMID: 31209739]
  32. Curr Diab Rep. 2007 Aug;7(4):257-64 [PMID: 17686400]
  33. Hypertension. 2020 Jan;75(1):237-245 [PMID: 31735081]
  34. PLoS One. 2018 Feb 2;13(2):e0192154 [PMID: 29394263]
  35. Stroke Vasc Neurol. 2019 Jun 24;4(2):105-107 [PMID: 31338222]
  36. Am J Physiol Heart Circ Physiol. 2003 Aug;285(2):H631-6 [PMID: 12750062]
  37. Eye Brain. 2021 Jun 17;13:159-173 [PMID: 34168513]
  38. Microvasc Res. 2019 Nov;126:103908 [PMID: 31376402]
  39. Eye (Lond). 2018 May;32(5):924-930 [PMID: 29456252]
  40. Am J Ophthalmol. 2006 Feb;141(2):394-6 [PMID: 16458708]
  41. PLoS One. 2021 Feb 11;16(2):e0246469 [PMID: 33571215]
  42. Adv Ophthalmol Pract Res. 2022 Feb 16;2(1):100036 [PMID: 37846223]
  43. Neurology. 1984 Jul;34(7):939-44 [PMID: 6610841]
  44. Sci Rep. 2020 Mar 17;10(1):4881 [PMID: 32184402]
  45. J Ophthalmol. 2018 Jul 30;2018:8538573 [PMID: 30151279]
  46. Sci Rep. 2018 Jul 24;8(1):11161 [PMID: 30042382]
  47. Ther Adv Ophthalmol. 2019 Aug 22;11:2515841419868100 [PMID: 31489400]
  48. Nutrients. 2022 Jun 14;14(12): [PMID: 35745192]
  49. J Neurol Sci. 2004 May 15;220(1-2):49-54 [PMID: 15140605]
  50. Int J Mol Sci. 2021 May 08;22(9): [PMID: 34066677]
  51. Sci Rep. 2021 Feb 10;11(1):3473 [PMID: 33568754]
  52. Nitric Oxide. 2018 Jul 1;77:75-87 [PMID: 29723581]
  53. Am J Ophthalmol. 2006 Jan;141(1):24-30 [PMID: 16386972]
  54. Surv Ophthalmol. 2016 Mar-Apr;61(2):164-86 [PMID: 26498862]
  55. Prog Retin Eye Res. 2021 May;82:100899 [PMID: 32890742]
  56. Alzheimer Dis Assoc Disord. 2014 Oct-Dec;28(4):366-7 [PMID: 23939264]

Word Cloud

Created with Highcharts 10.0.0patientsretinaldiseaseADPOAGhealthyflickercontrolsvesselanalysisp0vascularAlzheimer���sglaucomaRetinalreactivitylightcomparableRT=twodysfunctionPurpose:assesssimilaritiesdifferencesmicrovascularfunctionmildearly-stageprimaryopenangleMethods:flickeringassessed101920agematchedcontrolmeansdynamicDVAIMEDOSGmbHJenaGermanyaccordingestablishedprotocoladditionallyunderwentBPmeasurementsbloodglucoselipidmetabolismmarkersResults:demonstratedalterationsarteryformincreasedarterialreactiontimefinalcycle009replicated>05Furthermoresequentialchangesprogressingonethreefounddiffergroups001Conclusion:demonstratesignsarteriesearlystagesprocessprovidessupportconceptcommonunderlyingaetiologyneurodegenerativediseasesMicrovascularDysfunctionOccursEarlySimilarlyMildAlzheimer'sDiseasePrimary-OpenAngleGlaucomaPatients

Similar Articles

Cited By